Professional Documents
Culture Documents
03 Alerei InfluenzaAB IFU
03 Alerei InfluenzaAB IFU
Influenza A & B
Package Insert
CLIA COMPLEXITY: WAIVED - For Direct Nasal Swabs (Not Eluted in Viral Transport Media) Only
A Certificate of Waiver is required to perform this test in a CLIA Waived setting. To obtain CLIA waiver information and a Certificate of
Waiver, please contact your state health department. Additional CLIA waiver information is available at the Centers for Medicare and
Medicaid website at www.cms.hhs.gov/CLIA.
Failure to follow the instructions or modification to the test system instructions will result in the test no longer meeting the
requirements for waived classification.
CLIA COMPLEXITY: MODERATE – For Nasal or Nasopharyngeal Swabs Eluted in Viral Transport Media
Transfer Cartridges: White plastic components used to transfer 2 x 100 µL of sample extract from the Sample Receiver to
the Test Base.
Nasal Swabs: Sterile swabs for use with the Alere™ i Influenza A & B Test.
Positive Control Swab: The positive control swab is coated with inactivated influenza A and B viruses.
Negative Control Swab: The negative control swab is coated with inactivated Group C Streptococcus.
Package Insert
Quick Reference Guide
QUALITY CONTROL
Alere™ i Influenza A & B has built-in procedural controls. The result of the Procedural Control is displayed on the screen and is
automatically stored in the instrument with each test result. This can be reviewed later by selecting Review Memory on the instrument.
Procedural Controls:
Alere™ i Influenza A & B contains an internal control that has been designed to control for sample inhibition, amplification and assay
reagent function. In positive samples where target amplification is strong, the internal control is ignored and the target amplification
serves as the ‘control’ to confirm that the clinical sample was not inhibitory and that assay reagent performance was robust. At a very
low frequency, clinical samples can contain inhibitors that may generate invalid results.
Procedural Control Valid displayed on the instrument screen indicates that the assay reagents maintained their functional integrity and
the sample did not significantly inhibit assay performance.
External Positive and Negative Controls:
Good laboratory practice suggests the use of positive and negative controls to ensure that test reagents are working and that the test
is correctly performed. Alere™ i Influenza A & B kits contain Positive and Negative Control Swabs. These swabs will monitor the entire
assay. Test these swabs once with each new shipment received and once for each untrained operator. Further controls may be tested
in order to conform with local, state and/or federal regulations, accrediting groups, or your lab’s standard Quality Control procedures.
TEST PROCEDURE
Before testing with Alere™ i Influenza A & B:
• Allow all samples to reach room temperature.
• If stored at 2-8°C, allow the blue Sample Receiver to reach room temperature.
• The orange Test Base can be tested without the need to warm to room temperature.
A S D F G H J K L
# Z X C V B N M
123
Strep A Test
If the sample type has already been specified by the Admin, the instrument will automatically Please Select Sample Type
Enter Patient ID using on screen keyboard or barcode scanner Enter or Scan Patient ID
Touch ‘ ’.
Q W E R T Y U I O P
Verify that the ID was entered correctly, then touch ‘ ’ to confirm entry. A S D F G H J K L
# Z X C V B N M
123
Open the Lid and Insert Orange Test Base into Orange Test Base holder Insert test base
into device.
Caution: Do not apply excessive force. Excessive force could damage the instrument.
aution: Once the Test Base has been placed in the holder, the user will have 10 minutes
C
to confirm the test. If the test is not confirmed within 10 minutes, the instrument will time
out and the Test Base must be removed and discarded.
OK
If the incorrect Test Base has been inserted, remove and dispose of the incorrect Test Base. Close the
lid. The instrument will then run a self-test before proceeding to the Home screen. Press Run Test and
restart the test using the correct Test Base.
Step 3 Run Test Step 3 of 6
Insert Blue Sample Receiver into the Blue Sample Receiver holder Place sample
receiver in
Caution: Do not apply excessive force. Excessive force could damage the instrument. holder.
aution: Confirm that the foil seal on the Sample Receiver indicates that it is for use with
C
Alere™ i Influenza A & B. If not, then remove the Sample Receiver and replace it with a
new Sample Receiver for Alere™ i Influenza A & B.
aution: Once the Sample Receiver has been placed in the holder, the user will have
C
10 minutes to start the test (Steps 3 through 5). If the test is not started within 10 minutes,
the instrument will time out and all test pieces (Test Base and Sample Receiver) must be
removed and discarded. The instrument will proceed to the Home screen. Press Run Test
and restart the test using a new Test Base and Sample Receiver.
aution: DO NOT REMOVE THE FOIL SEAL UNTIL PROMPTED BY THE INSTRUMENT.
C Warming up
DO NOT close the lid or insert the sample until prompted by the instrument. 1:55 remaining
OK
Vigorously mix the swab in the liquid for 10 seconds. Press the swab head against the side of Run Test Step 4 of 6
the Sample Receiver as you mix it. This helps remove the sample from the swab. Once the swab is Remove seal.
removed, touch ‘OK’ to proceed. Mix swab for
10 seconds and
discard the swab
aution: To ensure the Sample Receiver remains in the instrument while removing the foil
C
(6:37)
seal, place two fingers along the outer edge of the Sample Receiver to hold it in place. If
the Sample Receiver spills after warm up, cancel the test by pressing the Home button. OK
Remove and discard the test pieces (Sample Receiver and Test Base) and clean the
instrument. Press Run Test to start a new test using a new Test Base and Sample Receiver.
Discard the swab.
Skip to Step 5a.
Nasal or Nasopharyngeal Swab Eluted in Viral Transport Media Test Procedure Run Test Step 4 of 6
Remove seal.
When prompted, remove the foil seal and add 0.2mL of sample to the Sample Receiver using Add 0.2 ml
of sample
a precision pipette with a disposable tip. and mix.
(6:37)
Vigorously mix the sample in the liquid for 10 seconds. Pipette the sample up and down while Run Test Step 4 of 6
swirling the pipette tip in the liquid. Once the sample is mixed and the pipette is removed, touch ‘OK’ Remove seal.
to proceed. Continue to Step 5a. Add 0.2 ml
of sample
and mix.
aution: To ensure the Sample Receiver remains in the instrument while removing the foil
C
(6:37)
seal, place two fingers along the outer edge of the Sample Receiver to hold it in place. If
the Sample Receiver spills after warm up, cancel the test by pressing the Home button.
Remove and discard the test pieces (Sample Receiver and Test Base) and clean the
instrument. Press Run Test to start a new test using a new Test Base and Sample Receiver.
Press the White Transfer Cartridge into the Blue Sample Receiver Press transfer
cartridge into
Listen for a click. receiver (click).
Attach cartridge
to test base
When the Transfer Cartridge is properly attached to the Sample Receiver, the orange indicator on the (orange indicator
descends)
Transfer Cartridge will rise. If the orange indicator does not rise, continue pushing onto the Sample
Receiver until it does.
aution: The orange indicator should be observed closely. If the orange indicator does not
C
fully rise, the Transfer Cartridge may not collect enough sample.
Lift and then connect the Transfer Cartridge to the Test Base Press transfer
cartridge into
When the Transfer Cartridge is properly attached to the Test Base, the orange indicator on the receiver (click).
Attach cartridge
Transfer Cartridge will descend. If the orange indicator does not descend, continue pushing onto the to test base
(orange indicator
Test Base until it does. descends)
aution: If the orange indicator does not fully descend, not enough sample will be
C
dispensed. This may potentially result in invalid or false negative results.
on the screen.
(0:25) Do not open.
aution: This screen will be displayed for up to 30 seconds once the Transfer Cartridge is detected. If the
C
instrument does not detect that the lid has been closed by then, it will time out and all test pieces (Sample
Receiver, Test Base, and Transfer Cartridge) must be removed and discarded. The instrument will proceed to the
Home screen. Collect a new sample from the patient. Press Run Test and restart the test using a new Test Base
and Sample Receiver.
aution: DO NOT OPEN THE LID. The test will be cancelled and all test pieces (Sample Receiver, Test Base, and
C
Transfer Cartridge) must be removed and discarded. A test result will not be reported or saved in the instrument
memory.
When amplification and detection is complete, the instrument will automatically save the data before Run Test
advancing to the results screen. Saving...
aution: The test is not saved until the completed result is displayed. Do not open the lid
C
until the results are displayed.
Flu A: Negative
Press Print to print test results, press New Test to run another test, Press Home to return to the
Flu B: Positive
Home screen
New Test Print
After printing, or if New Test or Home are selected, the instrument will prompt to open the lid and Self Test
discard the used test pieces. Open lid.
Remove test pieces by lifting the Transfer Cartridge attached to the Test Base, and clicking it into the
Sample Receiver, by pressing into the Sample Receiver.
aution: Do not try to remove the Sample Receiver by any other method as there is a risk
C
of spilling the patient sample.
All test pieces will be connected and can now be removed from the instrument and disposed of Discard Pieces
according to federal, state and local regulations. Attach test base/
se/
transfer cartridge
dge
Caution: DO NOT disassemble the Transfer Cartridge and the Test Base before disposal. onto sample
receiver and
discard
Close the lid. The instrument will then run a Self-Test before showing the Home screen or Enter Self Test
Patient ID screen, depending on the previous selection. Close lid to
start test.
Strep A Test
Positive QC Test
Negative QC Test
Confirm the test type to match the QC sample intended for testing by touching ‘OK’ and following Confirm test:
Influenza A & B Test
the on screen prompts to complete testing. Positive QC Test
Note: The QC test is run in the same manner as a Patient Test. See the To Perform a Test section
above for step by step instructions.
Cancel OK
RESULT INTERPRETATION
When the test is complete, the results are clearly displayed on the instrument screen. An individual result for both influenza A and
influenza B will be provided.
Flu A: Positive
subtype.
Flu B: Negative
Test Results Flu A Viral RNA Detected; The presence or absence of Flu B Viral RNA cannot be determined.
1/Jan/2014
Patient ID: 10AX425
11:22am
Procedural This result does not rule out co-infections with other pathogens or identify any specific influenza A virus
User ID: Alereuser1 Control Valid
Flu A: Positive
subtype.
Flu B: Invalid
Flu A: Negative
lineage.
Flu B: Positive
Test Results Flu B Viral RNA Detected; The presence or absence of Flu A Viral RNA cannot be determined.
1/Jan/2014
Patient ID: 10AX425
11:22am
Procedural This result does not rule out co-infections with other pathogens or identify any specific influenza B virus
User ID: Alereuser1 Control Valid
Flu A: Invalid
lineage.
Flu B: Positive
Test Results Flu A Viral RNA Detected; Flu B Viral RNA Detected.
1/Jan/2014
Patient ID: 10AX425
11:22am
Procedural Dual infections of Flu A and Flu B are rare. Repeat testing using new test components. Contact Technical
User ID: Alereuser1 Control Valid
Flu A: Positive
Support during normal business hours if multiple samples provide this result.
Flu B: Positive This result does not rule out co-infections with other pathogens or identify any specific influenza A or
influenza B virus lineage.
New Test Print
Test Results Flu A Viral RNA Not Detected; Flu B Viral RNA Not Detected.
1/Jan/2014 11:22am
Patient ID: 10AX425 Procedural
User ID: Alereuser1 Control Valid
Flu A: Negative
Flu B: Negative
Flu A: Negative
If repeated Flu B Invalid results are obtained, results should be confirmed by another method prior to
reporting the results.
Flu B: Invalid
Test Results Flu B Viral RNA Not Detected; The presence or absence of Flu A Viral RNA cannot be determined.
1/Jan/2014
Patient ID: 10AX425
11:22am
Procedural Infection due to Flu A cannot be ruled out. Repeat testing of the sample using new test components.
User ID: Alereuser1 Control Valid
Flu A: Invalid
If repeated Flu A Invalid results are obtained, results should be confirmed by another method prior to
reporting the results.
Flu B: Negative
Test Results The presence or absence of Flu A and Flu B Viral RNAs cannot be determined.
7/Feb/2013
Patient ID: 10AX425
11:22am
Repeat testing of the sample using new test components. If repeated Flu A and Flu B Invalid results are
Flu A: Invalid
obtained, results should be confirmed by another method prior to reporting the results.
Flu B: Invalid
Influenza A Positives by the Alere™ i Influenza A & B Assay per Age Group
Prospective Clinical Study During the Prospective Clinical Study During the
2012/2013 Influenza Season 2014/2015 Influenza Season
Number of Number of Nasal or
Number of Influenza A Number of
Direct Nasal Nasopharyngeal Swab Influenza A
Age Group Influenza A Positivity Influenza A
Swab Eluted in Viral Transport Positivity Rate
Positives Rate Positives
Specimens Media Specimens
<1 year 121 25 20.1% 173 21 12.1%
1 to 5 years 219 63 28.8% 533 95 17.8%
6 to 10 years 102 35 34.3% 238 75 31.5%
11 to 15 years 41 12 29.3% 115 30 26.1%
16 to 21 years 22 3 13.6% 35 5 14.3%
>21 to 60 years 71 18 25.4% 85 19 22.4%
>60 years 9 2 22.2% 64 11 17.2%
Total 585 158 27.0% 1243 256 20.6%
results for 16 specimens, resulting in a total of 571 specimens for influenza A performance analysis and 569 specimens for influenza B
performance analysis.
Direct Nasal Swab - Performance Obtained for Influenza A with Alere™ i Influenza A & B against Viral Culture
Alere™ i Culture
Influenza A & B – Flu A Positive Negative Total
Positive 92 66a 158
Negative 2 b
411 413
Total 94 477 571
Sensitivity: 92/94 97.9% (95%CI: 92.6%-99.4%)
Specificity: 411/477 86.2% (95%CI: 82.8%-89.0%)
a Flu A nucleic acid was detected in 58/66 False Positive specimens using an FDA-cleared molecular test
b Flu A nucleic acid was not detected in 1/2 False Negative specimens using an FDA-cleared molecular test
Direct Nasal Swab - Performance Obtained for Influenza B with Alere™ i Influenza A & B against Viral Culture
Alere™ i Culture
Influenza A & B – Flu B Positive Negative Total
Positive 74 17a
91
Negative 6b 472 478
Total 80 489 569
Sensitivity: 74/80 92.5% (95%CI: 84.6%-96.5%)
Specificity: 472/489 96.5% (95%CI: 94.5%-97.8%)
a Flu B nucleic acid was detected in 15/17 False Positive specimens using an FDA-cleared molecular test
b Flu B nucleic acid was not detected in 4/6 False Negative specimens using an FDA-cleared molecular test
Alere™ i Influenza A & B detected one mixed influenza A and B infection in the prospective clinical evaluation. This sample tested
positive for influenza B only by viral culture, but tested positive for influenza A only by an FDA cleared Influenza RT-PCR assay.
During the prospective clinical study, the initial invalid rate (before repeat testing per the product instructions) was 5.8% (34/585)
(95% CI: 4.2% to 8.0%) for Flu A, and 3.6% (21/585) (95% CI: 2.4% to 5.4%) for Flu B. After repeat testing per the product
instructions, the invalid rate was 2.4% (14/585) (95% CI: 1.4%, 4.0%) for Flu A, and 2.7% (16/585) (95% CI: 1.7%, 4.4%) for Flu B.
Nasal or Nasopharyngeal Swabs Eluted in Viral Transport Media - Performance Obtained for Influenza B with Alere™ i
Influenza A & B against the Comparator Method
Limit of Detection (LOD) Study Results - Natural Nasal Swab Matrix (Swab Eluted in VTM Testing)
B/Lee/40 Victoria 5.00 x 101 5.00 x 10-1 5.40 x 104 5.40 x 102 - +
Lineage CEID50/mL CEID50/Swab
B/Victoria/504/2000 Victoria 1.19 x 103 1.19 x 101 6.24 x 104 6.24 x 102 - +
Lineage
B/Nevada/03/2011 Victoria 1.75 x 103 1.75 x 101 8.29 x 104 8.29 x 102 - +
Lineage
B/Montana/05/2012 Victoria 9.00 x 101 9.00 x 10-1 2.55 x 104 2.55 x 102 - +
Lineage
B/Maryland/1/59 Yamagata 8.51 x 102 8.51 x 100 1.13 x 105 1.13 x 103 - +
Lineage
B/Russia/69 b Yamagata 4.44 x 101 4.44 x 10-1 2.96 x 106 2.96 x 104 - +
Lineage
An additional analytical reactivity study was also performed testing the same set of influenza A and B strains as described in the table
above following the test procedure for Nasal or Nasopharyngeal Swab Eluted in Viral Transport Media, and demonstrated equivalent
analytical reactivity performance to that of testing direct swab samples.
41 Alere™ i Influenza A & B Package Insert
Analytical Specificity (Cross Reactivity)
To determine the analytical specificity of Alere™ i Influenza A & B, 53 commensal and pathogenic microorganisms (37 bacteria,
15 viruses and 1 yeast) that may be present in the nasal cavity or nasopharynx were tested. All of the following microorganisms were
negative when tested at concentrations ranging from 108 to 1010 cells/mL, CFU/mL or IFU/mL (bacteria), 104 to 108 TCID50/mL or
CEID50/mL (viruses), and 108 cells/mL (yeast).
Untrained Users
Sample Type % Detection 95% CI
Influenza A Low Positive (at LOD) 100% (60/60) 94.0%, 100%
Influenza A High Negative (below LOD) 53% (32/60) 40.9%, 65.4%
Influenza B Low Positive (at LOD) 97% (58/60) 88.6%, 99.1%
Influenza B High Negative (below LOD) 8% (5/60) 3.6%, 18.1%
Negative Sample 0% (0/60) 0%, 6.0%
*10 invalid results were generated by the untrained users (3% (10/300) with 95% CI: 1.8%, 6.0%)
Using risk analysis as a guide, analytical flex studies were conducted on Alere™ i Influenza A & B. The studies demonstrated that the
test is insensitive to stresses of environmental conditions and potential user errors.
Fragile, handle with care Test Base Transfer Cartridge Sample Receiver Prescription Only
(Applies to U.S. only)
Asia Pacific
+61 7 3363 7711 APproductsupport@alere.com
Canada
+1 800 818 8335 CANproductsupport@alere.com
Latin America
+57 2 6618797 LAproductsupport@alere.com
REFERENCES
1. Williams, KM, Jackson MA, Hamilton M. Rapid Diagnostic Testing for URIs in Children: Impact on Physician Decision Making and
Cost. Infect. Med. 19(3): 109-111, 2002.
2. Bonner, A.B. et al. Impact of the Rapid Diagnosis of Influenza on Physician Decision-Making and Patient Management in the
Pediatric Emergency Department: Results of a Randomized, Prospective, Controlled Trial. Pediatrics. 2003 Vol. 112 No. 2.